Since 1992 SynCo’s facilities have been a licensed manufacturing site for drug substance and aseptically prepared small volume parenterals (drug product). SynCo’s GMP license covers both clinical and commercial supply of wide variety of biopharmaceutical products.
SynCo aims for a long term partnership and has brought several Live Microbial Projects over the past years, from early stage development through the clinical phases into commercial launch and production.
Some of the Live Microbial Products that SynCo has experience with are:
- Vibrio cholerae
- Salmonella typhi
- Multiple Lactobacillus spp.
- Oxalobacter formigenes
- Multiple Bifidobacterium spp.
- Saccharomyces cerevisiae